Estimates of anti-SARS-CoV-2 antibody seroprevalence in Iran.

Nazemipour, Maryam; Shakiba, Maryam; Mansournia, Mohammad Ali

Nazemipour, Maryam; Shakiba, Maryam; Mansournia, Mohammad Ali.

Nazemipour M; Psychosocial Health Research Institute, Iran University of Medical Sciences, Tehran, Iran.
Shakiba M; Cardiovascular Diseases Research Center and School of Health, Guilan University of Medical Sciences, Rasht, Iran.
Mansournia MA; Department of Epidemiology and Biostatistics, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran. Electronic address: mansournia_ma@yahoo.com.

Lancet Infect Dis ; 21(5): 603-604, 2021 05.

Article in English | MEDLINE | ID: covidwho-1111920

Subject(s)

COVID-19; SARS-CoV-2; Antibodies, Viral; Cities; Cross-Sectional Studies; Humans; Iran/epidemiology; Seroepidemiologic Studies

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: SARS-CoV-2 / COVID-19 Type of study: Observational study / Randomized controlled trials Limits: Humans Country/Region as subject: Asia Language: English Journal: Lancet Infect Dis Journal subject: Communicable Diseases Year: 2021 Document Type: Article Affiliation country: S1473-3099(21)00044-X

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google